Clinical trials recruiting for Immune Checkpoint Inhibitor

Phase breakdown

Drugs and treatments being studied

Self-screener

Recruiting trials

• Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
  NCT06227728 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 4 locations
• COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
  NCT06168032 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC
  NCT05754203 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC
  NCT07705438 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• LAG3 Expression in Triple Negative Breast Cancer
  NCT06259162 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Female · 1 location
• Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
  NCT06197581 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors
  NCT07058948 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
  NCT07644897 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Immune Checkpoint Inhibitor often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Immune Checkpoint Inhibitor trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.